Mice Lacking the Chemokine Receptor CCR1 Show Increased Susceptibility to Toxoplasma gondii Infection1
暂无分享,去创建一个
Joseph D. Schwartzman | Jane Collins | Philip M. Murphy | J. Schwartzman | I. Khan | J. Collins | P. Murphy | Ji-Liang Gao | L. Casciotti | Imtiaz A. Khan | Lori Casciotti | Ji-Liang Gao | Grant R. Yeaman | G. Yeaman
[1] E. Denkers,et al. Human Polymorphonuclear Leukocytes Produce IL-12, TNF-α, and the Chemokines Macrophage-Inflammatory Protein-1α and -1β in Response to Toxoplasma gondii Antigens , 1999, The Journal of Immunology.
[2] J. Djeu. Production of Interferon by Natural Killer Cells , 1983, Clinics in Immunology and Allergy.
[3] Y. Suzuki,et al. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. , 1989, Journal of immunology.
[4] E. Konishi,et al. Neutrophil chemotactic factors secreted from Toxoplasma gondii , 1991, Parasitology.
[5] R. Schreiber,et al. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. , 1988, Science.
[6] J. Damme. Interleukin-8 and related chemotactic cytokines , 1994 .
[7] S. McColl,et al. Regulation of chemokine gene expression in human peripheral blood neutrophils phagocytosing microbial pathogens. , 1998, Journal of immunology.
[8] C. Hunter,et al. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha , 1994, Infection and immunity.
[9] H. Broxmeyer,et al. Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1 , 1999, The Journal of experimental medicine.
[10] C. Hunter,et al. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis , 1995, Infection and immunity.
[11] M. Mitsuyama,et al. An essential role for endogenous interferon‐γ in the generation of protective T cells against Mycobacterium bovis BCG in mice , 1997, Immunology.
[12] A. Martella,et al. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. , 1993, Clinical immunology and immunopathology.
[13] A. Sher,et al. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. , 1991, Journal of immunology.
[14] J. Wastling,et al. Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function , 1995, Parasite immunology.
[15] A. Sher,et al. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. de Waal Malefyt,et al. Functional characterization of human IL-10. , 1992, International archives of allergy and immunology.
[17] A. Sher,et al. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. , 1992, Journal of immunology.
[18] A R Dunn,et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. , 1994, Blood.
[19] Y. Yu,et al. Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. , 1998, Journal of immunology.
[20] D B Corry,et al. Constructing polycompetitor cDNAs for quantitative PCR. , 1993, Journal of immunological methods.
[21] J. Schwartzman,et al. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Cisterna,et al. Kinetics and Regulation of NK Activity by Interleukin‐2 and Interferon in Acute Toxoplasmosis , 1991, Scandinavian journal of immunology.
[23] R. McLeod,et al. Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii. , 2000, International journal for parasitology.
[24] T. Schall,et al. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor , 1993, Cell.
[25] I. Khan,et al. IL‐10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice , 1995, Parasite immunology.
[26] P. Murphy,et al. Cloning and Differential Tissue-specific Expression of Three Mouse Chemokine Receptor-like Genes, Including the Gene for a Functional Macrophage Inflammatory Protein-1 Receptor (*) , 1995, The Journal of Biological Chemistry.
[27] Johnson Ll,et al. Exacerbation of toxoplasmosis in neutrophil-depleted mice. , 1996 .
[28] I. Khan,et al. Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice. , 1996, International immunology.
[29] Michael H. Kutner. Applied Linear Statistical Models , 1974 .
[30] Y. Suzuki,et al. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon , 1990, Infection and immunity.
[31] H. Broxmeyer,et al. Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1 , 1997, The Journal of experimental medicine.
[32] W. Hancock,et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. , 2000, The Journal of clinical investigation.
[33] E. Denkers,et al. Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-gamma-independent IL-12. , 1999, Journal of immunology.
[34] T. Standiford,et al. Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha , 1993, The Journal of experimental medicine.
[35] V. Barnett,et al. Applied Linear Statistical Models , 1975 .
[36] J. Sternberg,et al. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection , 1992, European journal of immunology.
[37] K. Seydel,et al. Epithelial cell-initiated inflammation plays a crucial role in early tissue damage in amebic infection of human intestine. , 1998, Gastroenterology.
[38] J. Collins,et al. IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. , 1998, Journal of immunology.
[39] B. Dewald,et al. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.
[40] L. Johnson. SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections , 1992, Infection and immunity.
[41] A. Floreani,et al. Oxygen-derived free radical production by peripheral blood neutrophils in chronic cholestatic liver diseases. , 1999, Hepato-gastroenterology.
[42] A. Luster,et al. Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.
[43] J. Boothroyd,et al. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction , 1989, Journal of clinical microbiology.
[44] A. Sher,et al. Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. , 1994, The Journal of eukaryotic microbiology.
[45] I. Khan,et al. Interleukin-12 enhances murine survival against acute toxoplasmosis , 1994, Infection and immunity.
[46] P. Puccetti,et al. An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. , 1997, Journal of immunology.
[47] A. Sher,et al. Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. , 1995, Ciba Foundation symposium.
[48] Y. Suzuki,et al. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii , 1996, The Journal of experimental medicine.
[49] P. Murphy. Chemokine receptors: structure, function and role in microbial pathogenesis. , 1996, Cytokine & growth factor reviews.
[50] A. Sher,et al. Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii , 1997, The Journal of experimental medicine.
[51] A. Luster,et al. Identification of a mouse eosinophil receptor for the CC chemokine eotaxin. , 1996, Biochemical and biophysical research communications.
[52] D. Remick,et al. Cytokines in Health and Disease , 1992 .
[53] L. Johnson,et al. Exacerbation of toxoplasmosis in neutrophil-depleted mice. , 1996, Natural immunity.
[54] G. Trinchieri,et al. Interleukin‐12 production by human polymorphonuclear leukocytes , 1995, European journal of immunology.
[55] Barry Halliwell,et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils , 1998, Nature.
[56] C. Wilson,et al. Activity of human blood leukocytes against Toxoplasma gondii. , 1979, The Journal of infectious diseases.